Fortress Biotech (FBIO) Q3 2026 Earnings Call Transcript
Emrosi momentum and a looming national payer win drive the story.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
More in Finance & Markets
Ukrainian-founded drone maker UForce raises $700 million at $6 billion valuation
The investment will help UForce expand production for Ukraine and supply allied countries with systems suited to modern warfare, the company said.
Wholesale prices rose 0.3% in October, slightly less than expected
The producer price index was expected to increase 0.4% in October, according to the Dow Jones consensus.
Hours-Long Microsoft Outage Disrupts Businesses, Governments Globally
A more than 12-hour outage of Microsoft Outlook and Teams crippled communications for businesses and governments globally on Friday, forcing some organizations to revert to fax machines and halting at…
QQQ Is in a Correction (Down 10%). Should You Buy More of This Popular Tech ETF?
The Invesco QQQ Trust offers exposure to major tech names leading the AI trade. That can be more risky during a tech stock sell-off.
- QQQ, a tech ETF, has declined 10% since October
- AI concerns include debt, data center backlash, productivity doubts
- AI stocks like Alphabet, Nvidia, Tesla down double-digits in 6 months
Wholesale prices rose 0.3% in October, putting annual rate at 6.5%, the highest in nearly four years
The producer price index was expected to increase 0.4% in October, according to the Dow Jones consensus.